Newron Pharmaceuticals
NWRN.SW
#8213
Rank
C$0.23 B
Marketcap
$12.02
Share price
2.15%
Change (1 day)
58.96%
Change (1 year)

Earnings for Newron Pharmaceuticals (NWRN.SW)

Earnings in 2023: -C$25.14 Million

According to Newron Pharmaceuticals's latest financial reports the company's current earnings are C$10.01 Million. In 2023 the company made an earning of -C$25.14 Million, an increase over its 2022 earnings that were of -C$26.31 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Newron Pharmaceuticals from 2005 to 2023

Annual earnings

Year Earnings Change
2023-C$25.14 Million-4.45%
2022-C$26.31 Million11.19%
2021-C$23.66 Million-30.14%
2020-C$33.87 Million6.84%
2019-C$31.71 Million31.45%
2018-C$24.12 Million170.13%
2017-C$8.93 Million-60.23%
2016-C$22.45 Million-41.46%
2015-C$38.34 Million109.46%
2014-C$18.31 Million22.43%
2013-C$14.95 Million222.49%
2012-C$4.64 Million-60.49%
2011-C$11.74 Million-71%
2010-C$40.47 Million-17.37%
2009-C$48.97 Million52.58%
2008-C$32.1 Million41.24%
2007-C$22.73 Million-25.19%
2006-C$30.38 Million22.45%
2005-C$24.81 Million